// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

The Association of Lupus Nephritis Histopathologic Classification with Venous Thromboembolism Is Modified by Age at Biopsy

Vimal Derebail - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Hydroxychloroquine

The Risk of Venous Thromboembolism in Patients with Psoriatic Disease and Rheumatoid Arthritis, a Population-based Study

Na Lu - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Anticoagulation Strategy in Patients with HeartMate II Undergoing Elective Surgery

Maya Guglin - Heart Failure Society of America (HFSA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Incidence and outcomes of bailout stenting following use of drug coated balloon

S Basavarajaiah - European Society of Cardiology (ESC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Paclitaxel

Clinical outcomes at two years of the Absorb BRS vs. the Xience metallic DES in patients presenting with ACS vs. stable coronary disease - AIDA trial substudy

R Y G Tijssen - European Society of Cardiology (ESC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Clinical outcome after coronary bifurcation stenting: a systematic review and network meta-Analysis of PCI bifurcation techniques comprising 5572 patients

G Di Gioia - European Society of Cardiology (ESC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Dual antiplatelet therapy to inhibit myocardial injury in patients with high-risk coronary artery plaque: a randomized controlled trial

A Moss - European Society of Cardiology (ESC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Ticagrelor

Elevated interleukin-6 and interleukin-18 concentrations predict residual inflammatory risk both before and after interleukin-1beta inhibition with canakinumab

PM Ridker - European Society of Cardiology (ESC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ILS-969

Updated meta-analysis of biodegradable polymer drug-eluting stent versus second-generation durable polymer drug-eluting stent implantations

JC Choe - European Society of Cardiology (ESC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Prognosis of patients with mid-range left ventricular ejection fraction treated with PCI: insight from the global leaders study.

P Chichareon - European Society of Cardiology (ESC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Biolimus A9

Revisiting Prosthesis Choice in Mitral Valve Replacement in Children: Mechanical and Stented Bovine Jugular Vein Graft Valves More Durable Than Bioprosthetic Alternatives

Perry Seo Choi - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Routine Surveillance for Screening and Diagnosis of Asymptomatic Venous Thromboembolism After Pleurotomy for Malignant Mesothelioma

Luis Eduardo De Leon - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Enoxaparin sodium

Fontan with Lateral Tunnel Is Associated with Improved Survival Compared to Extracardiac Conduit

Viktoria H. M. Weixler - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

SUN-606 Thyroid Cancer Presenting As Acute Limb Ischemia

FNU Shashpal - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Dabrafenib Mesylate

SUN-581 An Unusual Presentation of Hypothyroidism

Hussam Alim - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Venous thrombosis

Levothyroxine

SUN-210 Testosterone Replacement Therapy Implicated in Osteonecrosis

Almira Yang, DO - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Venous thrombosis

FVIII

SUN-206 Acute Cardiovascular Complications FromTestosterone Therapy

Mohamed Shakir - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Atorvastatin

SUN-150 Complications of DKA in Teaching Vs. Non-Teaching Hospitals

Yasaman Motlaghzadeh - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

SUN-LB025 Superior Mesenteric Artery Thrombosis: An Uncommon Complication of Diabetic Ketoacidosis

Khushpreet Kaur Saini - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

Protein C

SUN-060 Statin-Resistant Hyperlipidemia: Role of Lipoprotein (a)

Kelvin Tran, DO - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Atorvastatin

Copyright © 2026. QuantiNova All rights reserved